Your session is about to expire
← Back to Search
Overnight Orthokeratology Lenses for Near-Sightedness (Acuity200OK Trial)
Acuity200OK Trial Summary
This trial is to collect safety & effectiveness data on a contact lens for overnight wear that can be submitted to the FDA to get approval.
Acuity200OK Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Acuity200OK Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many medical centers are currently conducting this research endeavor?
"This medical trial is currently recruiting from 13 sites scattered across Oakland, San Francisco, Sunnyvale and other cities. To make participation more convenient for patients, it is suggested that they opt to enrol in the location nearest them."
Is enrollment still available for this medical experiment?
"According to the information on clinicaltrials.gov, recruitment for this particular medical trial has already concluded. It was initially posted in September of 2023 and last updated three weeks ago. Nevertheless, there are still 119 other active trials that may be suitable for potential candidates."
What are the core aims of this medical research?
"According to the clinical trial sponsor, Acuity Polymers Inc., the primary outcome of this study will be evaluated over a 12 month period and is Attempted vs. Achieved Reduction in manifest refractive error. Secondary measures include Change in best corrected spectacle visual acuity (BCSVA) from at all visits stratified by baseline pretreatment diopteric group., Pre-treatment manifest sphere in comparison to post-treatment manifest sphere stratified by dioptric power for all completed subjects at the 1 month visit and later visit intervals (3, 6, 9, and 12 month visits), as well as A level of attempted versus achieved"
Share this study with friends
Copy Link
Messenger